In order to identify novel agents for pancreatic cancer treatment targeting protein kinases involved in the cancer metabolism and still unexplored, we mainly focus our attention on reviewing the progress made in the development of PDKs inhibitors. The gene discussed is WEE1; the disease is pancreatic neoplasm.